The Unseen Nephrological Risk of GLP-1s
When prescribing Semaglutide or Tirzepatide, physicians routinely caution patients about nausea and constipation.
However, nephrologists have identified a far more serious hazard: Acute Kidney Injury (AKI) and nephrolithiasis (kidney stones) secondary to hypovolemia.
---
How GLP-1s Inadvertently Suppress Thirst
GLP-1 receptor agonists cross the blood-brain barrier to bind to receptors in the subfornical organ and median preoptic nucleus of the hypothalamus.
While this suppresses hunger and emotional food cravings, it also blunts dipsogenic osmocontrol — your physiological thirst reflex.
Patients simply forget to drink water. Combined with occasional vomiting, diarrhea, or low caloric intake, plasma volume drops, triggering: - Prerenal Azotemia: Elevated blood urea nitrogen (BUN) and serum creatinine. - Concentrated Tubular Solutes: Massive increases in urinary uric acid and calcium oxalate saturation. - Electrolyte Exhaustion: Low potassium and magnesium leading to muscle cramps and cardiac palpitations.
---
